Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SafeTy and Efficacy of Direct Oral Anticoagulant Versus Aspirin for Reduction Of RisK of CErebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation (STROKE-VT)

NCT02666742 is registered in ClinicalTrials.gov with Kansas City Heart Rhythm Institute as lead sponsor.

NCT NCT02666742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02666742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SafeTy and Efficacy of Direct Oral Anticoagulant Versus Aspirin for Reduction Of RisK of CErebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation (STROKE-VT)
Lead sponsor
Kansas City Heart Rhythm Institute
Phase
Phase 4
Overall status
Completed
Start date
February 16, 2017
Completion date
April 30, 2021
Enrollment
246 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

premature ventricular contraction, stroke, ventricular tachycardia